undergo chemotherapy for any one of the following settings: 1. Setting 1: Neoadjuvant chemotherapy prior to cheom-RT 2. Setting 2: Palliative chemotherapy in Chemonaive patients 3. Setting 3: Palliative chemotherapy in previously treated patients (i.e. 2nd line or 3rd line chemo) [clinicaltrials_resource:341b30e1f4eb69098b80c55ccaaaf699]
inclusion criteria [clinicaltrials_vocabulary:inclusion-criteria]
undergo chemotherapy for any one of the following settings: 1. Setting 1: Neoadjuvant chemotherapy prior to cheom-RT 2. Setting 2: Palliative chemotherapy in Chemonaive patients 3. Setting 3: Palliative chemotherapy in previously treated patients (i.e. 2nd line or 3rd line chemo) [clinicaltrials_resource:341b30e1f4eb69098b80c55ccaaaf699]
Bio2RDF identifier
341b30e1f4eb69098b80c55ccaaaf699
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:341b30e1f4eb69098b80c55ccaaaf699
identifier
clinicaltrials_resource:341b30e1f4eb69098b80c55ccaaaf699
title
undergo chemotherapy for any o ...... line or 3rd line chemo)
@en
type
label
undergo chemotherapy for any o ...... b30e1f4eb69098b80c55ccaaaf699]
@en